Immune checkpoint inhibitors and response analysis: a tough challenge. A case report

BACKGROUND: Treatment of metastatic NSCLC patients with immune-checkpoint medicine is intriguing for the potential efficacy; however it may be difficult to evaluate the clinical response due to the lack of reliable immune-monitoring markers up to now and the possibility of radiological pseudo-progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bearz, Alessandra, Perin, Tiziana, Cancian, Luca, Berto, Eleonora, Sartor, Ivana, Tirelli, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950698/
https://www.ncbi.nlm.nih.gov/pubmed/27431235
http://dx.doi.org/10.1186/s13104-016-2153-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950698/
https://www.ncbi.nlm.nih.gov/pubmed/27431235
http://dx.doi.org/10.1186/s13104-016-2153-9

Ejemplares similares